Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders

Overview of attention for article published in Cell Reports Medicine, April 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 8 news outlets
blogs: 2 blogs
twitter: 19 X users

patent: 1 patent
facebook: 1 Facebook page

Readers on

mendeley: 79 Mendeley

So far, Altmetric has seen 9 news stories from 8 outlets.

Neurofilament Light Clears First Hurdle as Bona Fide FTD Biomarker

Alzforum, 28 May 2024

28 May 2024 Even before the first flicker of symptoms surface in a person who carries a pathogenic frontotemporal dementia…

ALZFORUM | NETWORKING FOR A CURE

Alzforum, 06 May 2022

Gendron TF, Heckman MG, White LJ, Veire AM, Pedraza O, Burch AR, Bozoki AC, Dickerson BC, Domoto-Reilly K, Foroud T, Forsberg LK…

New blood biomarker may lead to early diagnosis of frontotemporal dementia

Healio.com, 21 Apr 2022

April 21, 2022 1 min read Source/Disclosures Disclosures: Gendron and Petrucelli are employed by the Mayo Clinic.

News Blood Biomarker for Frontotemporal Dementia Affirmed Researchers at the Mayo clinic have reported that neurofilament light is a biomarker for frontotemporal dementia, potentially allowing for quicker diagnoses.

Technology Networks, 20 Apr 2022

A test of protein in the blood gets further support as a biomarker for patients diagnosed with frontotemporal dementia (FTD), a…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 5 additional news stories.